252 related articles for article (PubMed ID: 36142738)
1. The Roles of Mitophagy and Autophagy in Ineffective Erythropoiesis in β-Thalassemia.
Chaichompoo P; Svasti S; Smith DR
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142738
[TBL] [Abstract][Full Text] [Related]
2. Improving Ineffective Erythropoiesis in Thalassemia: A Hope on the Horizon.
Madan U; Bhasin H; Dewan P; Madan J
Cureus; 2021 Oct; 13(10):e18502. PubMed ID: 34754662
[TBL] [Abstract][Full Text] [Related]
3. Enhanced activation of autophagy in β-thalassemia/Hb E erythroblasts during erythropoiesis.
Lithanatudom P; Wannatung T; Leecharoenkiat A; Svasti S; Fucharoen S; Smith DR
Ann Hematol; 2011 Jul; 90(7):747-58. PubMed ID: 21221583
[TBL] [Abstract][Full Text] [Related]
4. HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia.
Arlet JB; Ribeil JA; Guillem F; Negre O; Hazoume A; Marcion G; Beuzard Y; Dussiot M; Moura IC; Demarest S; de Beauchêne IC; Belaid-Choucair Z; Sevin M; Maciel TT; Auclair C; Leboulch P; Chretien S; Tchertanov L; Baudin-Creuza V; Seigneuric R; Fontenay M; Garrido C; Hermine O; Courtois G
Nature; 2014 Oct; 514(7521):242-6. PubMed ID: 25156257
[TBL] [Abstract][Full Text] [Related]
5. Increased autophagy leads to decreased apoptosis during β-thalassaemic mouse and patient erythropoiesis.
Chaichompoo P; Nithipongvanitch R; Kheansaard W; Tubsuwan A; Srinoun K; Vadolas J; Fucharoen S; Smith DR; Winichagoon P; Svasti S
Sci Rep; 2022 Nov; 12(1):18628. PubMed ID: 36329049
[TBL] [Abstract][Full Text] [Related]
6. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.
Dussiot M; Maciel TT; Fricot A; Chartier C; Negre O; Veiga J; Grapton D; Paubelle E; Payen E; Beuzard Y; Leboulch P; Ribeil JA; Arlet JB; Coté F; Courtois G; Ginzburg YZ; Daniel TO; Chopra R; Sung V; Hermine O; Moura IC
Nat Med; 2014 Apr; 20(4):398-407. PubMed ID: 24658077
[TBL] [Abstract][Full Text] [Related]
7. Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus.
Zurlo M; Zuccato C; Cosenza LC; Gasparello J; Gamberini MR; Stievano A; Fortini M; Prosdocimi M; Finotti A; Gambari R
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894732
[TBL] [Abstract][Full Text] [Related]
8. Protein quality control during erythropoiesis and hemoglobin synthesis.
Khandros E; Weiss MJ
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1071-88. PubMed ID: 21075281
[TBL] [Abstract][Full Text] [Related]
9. Differential regulatory and compensatory responses in hematopoiesis/erythropoiesis in alpha- and beta-globin hemizygous mice.
Beauchemin H; Blouin MJ; Trudel M
J Biol Chem; 2004 May; 279(19):19471-80. PubMed ID: 15004025
[TBL] [Abstract][Full Text] [Related]
10. Thalassemia: pathophysiology of red cell changes.
Schrier SL
Annu Rev Med; 1994; 45():211-8. PubMed ID: 8198378
[TBL] [Abstract][Full Text] [Related]
11. Novel players in β-thalassemia dyserythropoiesis and new therapeutic strategies.
Arlet JB; Dussiot M; Moura IC; Hermine O; Courtois G
Curr Opin Hematol; 2016 May; 23(3):181-8. PubMed ID: 26779615
[TBL] [Abstract][Full Text] [Related]
12. Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia.
Suragani RN; Cawley SM; Li R; Wallner S; Alexander MJ; Mulivor AW; Gardenghi S; Rivella S; Grinberg AV; Pearsall RS; Kumar R
Blood; 2014 Jun; 123(25):3864-72. PubMed ID: 24795345
[TBL] [Abstract][Full Text] [Related]
13. Imbalanced globin chain synthesis determines erythroid cell pathology in thalassemic mice.
Srinoun K; Svasti S; Chumworathayee W; Vadolas J; Vattanaviboon P; Fucharoen S; Winichagoon P
Haematologica; 2009 Sep; 94(9):1211-9. PubMed ID: 19608680
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of beta thalassemia--a guide to molecular therapies.
Thein SL
Hematology Am Soc Hematol Educ Program; 2005; ():31-7. PubMed ID: 16304356
[TBL] [Abstract][Full Text] [Related]
15. Altered erythropoiesis and iron metabolism in carriers of thalassemia.
Guimarães JS; Cominal JG; Silva-Pinto AC; Olbina G; Ginzburg YZ; Nandi V; Westerman M; Rivella S; de Souza AM
Eur J Haematol; 2015 Jun; 94(6):511-8. PubMed ID: 25307880
[TBL] [Abstract][Full Text] [Related]
16. XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia.
Guillem F; Dussiot M; Colin E; Suriyun T; Arlet JB; Goudin N; Marcion G; Seigneuric R; Causse S; Gonin P; Gastou M; Deloger M; Rossignol J; Lamarque M; Choucair ZB; Gautier EF; Ducamp S; Vandekerckhove J; Moura IC; Maciel TT; Garrido C; An X; Mayeux P; Mohandas N; Courtois G; Hermine O
Haematologica; 2020 Sep; 105(9):2240-2249. PubMed ID: 33054049
[TBL] [Abstract][Full Text] [Related]
17. Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia.
Manolova V; Nyffenegger N; Flace A; Altermatt P; Varol A; Doucerain C; Sundstrom H; Dürrenberger F
J Clin Invest; 2019 Dec; 130(1):491-506. PubMed ID: 31638596
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of heme oxygenase ameliorates anemia and reduces iron overload in a β-thalassemia mouse model.
Garcia-Santos D; Hamdi A; Saxova Z; Fillebeen C; Pantopoulos K; Horvathova M; Ponka P
Blood; 2018 Jan; 131(2):236-246. PubMed ID: 29180398
[TBL] [Abstract][Full Text] [Related]
19. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
Malik P; Arumugam PI; Yee JK; Puthenveetil G
Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
[TBL] [Abstract][Full Text] [Related]
20. 2021 update on clinical trials in β-thalassemia.
Musallam KM; Bou-Fakhredin R; Cappellini MD; Taher AT
Am J Hematol; 2021 Nov; 96(11):1518-1531. PubMed ID: 34347889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
